The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4'-Pyrazinimidoylamino-biphenyl-4-yl)-pyrazine-2-carboxamidine ID: ALA2316315
PubChem CID: 71569231
Max Phase: Preclinical
Molecular Formula: C22H18N8
Molecular Weight: 394.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N=C(Nc1ccc(-c2ccc(NC(=N)c3cnccn3)cc2)cc1)c1cnccn1
Standard InChI: InChI=1S/C22H18N8/c23-21(19-13-25-9-11-27-19)29-17-5-1-15(2-6-17)16-3-7-18(8-4-16)30-22(24)20-14-26-10-12-28-20/h1-14H,(H2,23,29)(H2,24,30)
Standard InChI Key: COQJQPYQZUAADF-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
25.3559 -25.4903 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.7810 -24.7896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3868 -24.0733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5676 -24.0564 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.1443 -24.7618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5410 -25.4752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3273 -24.7482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9304 -24.0339 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9070 -25.4491 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7708 -22.6018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3556 -23.3084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7600 -24.0191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5792 -24.0244 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9925 -23.3131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5858 -22.6053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8097 -23.3151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2166 -24.0238 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2200 -22.6083 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.0338 -24.0257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4376 -24.7365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2540 -24.7389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6652 -24.0316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2539 -23.3205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4388 -23.3217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4794 -24.0303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8867 -24.7401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7031 -24.7413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1133 -24.0335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7011 -23.3230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8860 -23.3253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
14 16 1 0
16 17 1 0
16 18 2 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
22 25 1 0
28 8 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 394.44Molecular Weight (Monoisotopic): 394.1654AlogP: 3.81#Rotatable Bonds: 5Polar Surface Area: 123.32Molecular Species: NEUTRALHBA: 6HBD: 4#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.80CX LogP: 1.73CX LogD: 1.73Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.30Np Likeness Score: -0.65
References 1. Arya S, Kumar N, Roy P, Sondhi SM.. (2013) Synthesis of amidine and bis amidine derivatives and their evaluation for anti-inflammatory and anticancer activity., 59 [PMID:23202484 ] [10.1016/j.ejmech.2012.10.046 ]